UVA Health researchers are advancing a technology that may allow new vaccines to be designed, tested and distributed in weeks ...
UVA Health scientists are reporting promising success as they pioneer a new way to create vaccines far more quickly, nimbly ...
Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...
INCHEON, South Korea, Jan. 22, 2026 /PRNewswire/ -- SK bioscience announced that it is advancing the development of a Zaire ...
Vaccine development is traditionally driven by financial return opportunities for investors, disease outbreaks, and a specific focus on emerging diseases. However, a new systematic, transparent, and ...
With $30 million in funding from the Coalition for Epidemic Preparedness Innovations (CEPI), Merck & Co. | The project, which involves Merck, SK Biosciences, Hilleman Laboratories and CDMO IDT ...
SK bioscience Co., a biopharmaceutical arm of South Korea's SK Group, said Thursday it will accelerate the development of a Zaire Ebola virus vaccine with funding from the Coalition for Epidemic ...
Jan 21 (Reuters) - Merck & Co unit MSD and the Coalition for Epidemic Preparedness Innovations said on Wednesday they have ...
Senior Manufacturing Science Associate Diane Morgan performs an analysis of plasmid DNA at Vernal Biosciences in Colchester on Tuesday, Aug. 12. Photo by Glenn Russell/VTDigger U.S. Health and Human ...
Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...
In a vaccine market with severe homogenization, differentiation is the strongest competitive advantage. AIM's iterative process high-efficiency diploid rabies vaccine demonstrates significant ...
Jan 21 (Reuters) - Merck and the Coalition for Epidemic Preparedness Innovations said on Wednesday they have partnered on a ...